双源CT对原发性胃淋巴瘤和进展期胃癌的鉴别诊断价值

doi:10.16150/j.1671-2870.2018.01.011

摘要/Abstract

摘要： 目的：对原发性胃淋巴瘤（primary gastric lymphoma, PGL）与进展期胃癌（advanced gastric cancer, AGC）的双源CT表现特点及病灶碘浓度进行比较,探讨双源CT鉴别诊断PGL与GC的临床应用价值。方法：回顾性收集我院经病理证实的50例PGL患者及50例AGC患者,对病灶的以下特征进行测量、比较和分析。特征包括①胃壁增厚的程度,②有无黏膜白线征,③病灶累及胃壁的范围,④病灶的强化程度,⑤病灶的碘浓度值。从中寻求适宜的鉴别诊断标准并予以评估。结果：PGL患者与AGC患者间的胃壁增厚程度（P=0.874）、病灶累及范围（P=0.718）差异均无统计学意义。与PGL患者相比,AGC患者的黏膜白线征阳性率更高（64%比24%, χ²=16.234, P<0.0001）,病灶强化更明显[(45.52±18.0) HU比(30.72±10.6) HU, P<0.001],病灶碘浓度值更高[（2.31±0.50) g/mL比(2.00±0.23) g/mL, P<0.001]。单独以黏膜白线征阳性、强化程度≥34.5 HU、碘浓度值≥2.25 g/mL诊断AGC的灵敏度分别为64%、76%和56%,特异度分别为76%、70%和88%。黏膜白线征与强化程度2项指标对于AGC的诊断灵敏度和特异度中等,考虑将二者联合应用,并联诊断AGC的灵敏度和特异度分别达90%和50%;串联诊断AGC的灵敏度和特异度分别达50%和96%。结论：应用双源CT获得的黏膜白线征、病灶强化程度和碘浓度值对于PGL与AGC的鉴别诊断具有一定价值。推荐以病灶碘浓度值≥2.25 g/mL为标准对AGC进行特异诊断;可将黏膜白线征阳性与强化程度≥34.5 HU并联诊断AGC,以提高诊断灵敏度。

关键词: 原发性胃淋巴瘤, 进展期胃癌, 诊断

Abstract: Objective: To compare the CT findings and iodine concentration between primary gastric lymphoma (PGL) and advanced gastric cancer (AGC), and to evaluate the diagnostic efficacy of dual-source CT in differentiating PGL from AGC. Methods: A total of 50 PGL patients and 50 AGC patients were enrolled. Characteristics of the lesions on CT imaging were recorded, including gastric wall thickness, 'white line' sign of mucosa, sites involved, enhancement degree, and iodine concentration. Results: No significant difference in gastric wall thickness(P=0.874) or sites of stomach involved (P=0.718) were found between PGL and AGC groups. The AGC group had higher positive rate of 'white line' sign of mucosa (64% vs 24%, χ²=16.234, P<0.0001), higher enhancement degree [(45.52±18.0) HU vs (30.72±10.6) HU, P<0.001] and higher iodine concentration [(2.31±0.50) g/mL vs (2.00±0.23) g/mL, P<0.001] than those of PGL group. For diagnosis of AGC, the sensitivity of positive 'white line' sign of mucosa, enhancement ≥34.5 HU and iodine concentration ≥2.25 g/mL were 64%, 76% and 56%, respectively, and the specificity were 76%, 80% and 88%, respectively. Conclusions: The 'white line' sign of mucosa, the enhancement degree, the iodine concentration acquired by dual-source CT are capable of differentiating PGL from AGC. A criterion of iodine concentration ≥2.25 g/mL is recommended for diagnosing AGC. A combined criteria of positive 'white line' sign of mucosa and enhancement ≥34.5 HU in parallel is recommended for the sensitive diagnosis of AGC, with a sensitivity of 90%.

Key words: Primary gastric lymphoma, Advanced gastric Cancer, Differential diagnosis

中图分类号:

R735.2

武新洋, 张欢, 潘自来, 谭晶文, 杲霄源. 双源CT对原发性胃淋巴瘤和进展期胃癌的鉴别诊断价值[J]. 诊断学理论与实践, 2018, 17(01): 60-65.

WU Xinyang, ZHANG Huan, PAN Zilai, TAN Jingwen, GAO Xiaoyuan. The diagnostic value of dual-source CT in differentiating primary gastric lymphoma from advanced gastric cancer[J]. Journal of Diagnostics Concepts & Practice, 2018, 17(01): 60-65.

参考文献

[1] Doglioni C, Ponzoni M, Ferreri AJ, et al. Gastric lymphoma: the histology report[J]. Dig Liver Dis,2011,43 Suppl 4:S310-S318.
[2] Chang ST, Menias CO.Imaging of primary gastrointestinal lymphoma[J]. Semin Ultrasound CT MR,2013,34(6):558-565.
[3] 冯琦, 庄治国, 许建荣. 胃癌MSCT扫描中征象学改变的初步小结[J]. 中国医学计算机成像杂志,2007,13(2):93-96.
[4] Lee SH, Hur J, Kim YJ, et al.Additional value of dual-energy CT to differentiate between benign and malignant mediastinal tumors: an initial experience[J]. Eur J Radiol,2013,82(11):2043-2049.
[5] Mileto A, Marin D, Alfaro-Cordoba M, et al.Iodine quantification to distinguish clear cell from papillary renal cell carcinoma at dual-energy multidetector CT: a multireader diagnostic performance study[J]. Radiology,2014,273(3):813-820.
[6] Yamauchi H, Buehler M, Goodsitt MM, et al.Dual-Energy CT-Based Differentiation of Benign Posttreatment Changes From Primary or Recurrent Malignancy of the Head and Neck: Comparison of Spectral Hounsfield Units at 40 and 70 keV and Iodine Concentration[J]. Am J Roentgenol,2016,206(3):580-587.
[7] Padhi S, Paul TR, Challa S, et al.Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis[J]. Asian Pac J Cancer Prev,2012,13(10):4889-4895.
[8] Rahman R, Asombang AW, Ibdah JA.Characteristics of gastric cancer in Asia[J]. World J Gastroenterol,2014, 20(16):4483-4490.
[9] Dawson IM, Cornes JS, Morson BC.Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis[J]. Br J Surg,1961,49:80-89.
[10] Wang YG, Zhao LY, Liu CQ, et al.Clinical characteristics and prognostic factors of primary gastric lymphoma: A retrospective study with 165 cases[J]. Medicine (Baltimore),2016,95(31):e4250.
[11] Vitolo U, Seymour JF, Martelli M, et al.Extranodal diffuse large B-cell lymphoma (DLBCL) and primary medias-tinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol,2016,27(Suppl 5):v91-v102.
[12] Mishima Y, Terui Y, Yokoyama M, et al.R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma[J]. Exp Hematol Oncol,2012,1(1):30.
[13] Lee DH, Kim SH, Joo I, et al.CT Perfusion evaluation of gastric cancer: correlation with histologic type[J]. Eur Radiol,2018,28(2):487-495.
[14] 范卫君, 吕衍春, 刘立志, 等. 胃癌和胃淋巴瘤的CT表现对比分析[J]. 癌症,2008,27(5):539-543.
[15] Kerbel RS.Tumor angiogenesis[J]. N Engl J Med,2008, 358(19): 2039-2049.
[16] Barzi A, Thara E.Angiogenesis in esophageal and gastric cancer: a paradigm shift in treatment[J]. Expert Opin Biol Ther,2014,14(9):1319-1332.
[17] Scartozzi M, Giampieri R, Loretelli C, et al.Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients[J]. Pharmacogenomics,2013,14(16):1991-1998.
[18] Tsurumaru D, Miyasaka M, Muraki T, et al.Diffuse-type gastric cancer: specific enhancement pattern on multiphasic contrast-enhanced computed tomography[J]. Jpn J Radiol,2017,35(6):289-295.
[19] Ba-Ssalamah A, Muin D, Schernthaner R, et al.Texture-based classification of different gastric tumors at contrast-enhanced CT[J]. Eur J Radiol,2013,82(10):e537-e543.
[20] Gupta R, Phan CM, Leidecker C, et al.Evaluation of dual-energy CT for differentiating intracerebral hemorrhage from iodinated contrast material staining[J]. Radiology,2010,257(1):205-211.
[21] Brown CL, Hartman RP, Dzyubak OP, et al.Dual-energy CT iodine overlay technique for characterization of renal masses as cyst or solid: a phantom feasibility study[J]. Eur Radiol,2009,19(5):1289-1295.
[22] Apfaltrer P, Meyer M, Meier C, et al.Contrast-enhanced dual-energy CT of gastrointestinal stromal tumors: is iodine-related attenuation a potential indicator of tumor response?[J]. Invest Radiol,2012,47(1):65-70.
[23] Dai X, Schlemmer HP, Schmidt B, et al.Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib[J]. Eur J Radiol,2013,82(2):327-334.
[24] Tang L, Li ZY, Li ZW, et al.Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression[J]. Clin Radiol,2015,70(11):1198-1204.